4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001213900-24-078214
Chief Operating Officer sold 900 shares at $21.23 ($19,104)
- Chief Operating Officer acquired 900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mahal Jeetinder Singh · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +900 | $7.10 | $6,390 | 25,909 | D |
| 2024-09-12 | Sale : show line 2 in the form 10b5-1 | −900 | $21.23 | $19,104 | 25,009 | D |
| Open-market sales · 900 sh · avg $21.23 · $19,104 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-12 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | +900 | 14,672 | D |
Loading xslF345X05/ownership.xml…